Melanoma researcher Rikki Brown with Professor
The survival rates for many cancers have improved as a direct result of medical research. However, the prognosis remains poor for some patients who are either unsuitable for or resistant to drug therapies. This includes melanoma patients.
The Kirkbride Centre is conducting world-class research, in collaboration with international colleagues, to find the answers to the causes of melanoma and to search for innovative new treatments.
Current research projects undertaken within the Harry Perkins Institute of Medical Research include the use of proteins to slow down and destroy tumours, the examination of genes that can prevent UV-induced melanoma and screening drug combinations (compound) to find a new compound with the ability to destroy melanoma cells.